Antibodies and fragments thereof to Fas ligand and Fas...

Details Antibodies and fragments thereof to Fas ligand and Fas... Antibodies and fragments thereof to Fas ligand and Fas...

2005-05-24

2005-05-24

Kemmerer, Elizabeth (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S300000, C530S350000, C530S388100, C530S389100, C530S387700, C530S387900

Reexamination Certificate

active

06897295

ABSTRACT:
This invention provides a novel polypeptide useful in the field of medicines, a novel DNA which encodes the novel polypeptide, a recombinant DNA molecule which contains the novel DNA, a transformant transformed with the novel DNA or the recombinant DNA molecule, a process for the purification of the novel polypeptide, a process for the production of the novel polypeptide, an antibody which recognizes the novel polypeptide, an oligonucleotide complementary to the novel DNA and a novel screening method. Particularly this invention provides a novel polypeptide which is Fas ligand or a fragment thereof. This novel polypeptide can be used as an effective ingredient of a medicament for regulating the apoptosis in a living body. This novel polypeptide is obtained by identifying a DNA fragment which encodes the novel polypeptide, transforming a desired host with a recombinant DNA molecule which contains the DNA fragment and purifying the novel polypeptide produced by the resulting transformant. This novel polypeptide has a cytoplasmic domain, a transmembrane domain and extracellular domain and takes part in apoptosis.

REFERENCES:
patent: 5436154 (1995-07-01), Barbanti et al.
patent: 0510691 (1992-10-01), None
patent: WO9110448 (1991-07-01), None
patent: WO9518819 (1995-07-01), None
Harlow et al. Antibodies, A Laboratory Manual, p. 76, 1988.*
Hsu et al. Am. J. Pathol. 135, 735-745, 1989.*
Yonehara et al, J. Exp. Med., vol. 169, pp. 1747-1756 (May 1989).
Itoh et al, Cell, vol. 66, pp. 233-243 (Jul. 26, 1991).
Watanabe-Fukunaga et al, The Journal of Immunology, vol. 148, No. 4, pp. 1274-1279 (Feb. 15, 1992).
Kobayashi et al, Nikkei Science, vol. 6, pp. 34-41 (1993).
Ogasawara et al, Nature, vol. 364, pp. 806-809 (Aug. 26, 1993).
Hiramatsu et al, Hepatology, vol. 19, No. 6, pp. 1354-1359 (Jun. 1994).
Watanabe-Fukunaga et al, Nature, vol. 356, pp. 314-317 (Mar. 26, 1992).
Rouvier et al, J. Exp. Med., vol. 177, pp. 195-200 (Jan. 1993).
Morimoto et al, Cancer Research, vol. 53, pp. 2591-2596 (Jun. 1, 1993).
Kimura et al, Biochem. and Biophys. Res. Comm., vol. 198., No. 2, pp., 666-674 (Jan. 28, 1994).
Creieghton, J. Mol. Biol., vol. 87, pp. 563-577 (1974).
Itoh et al, The Journal of Immunology, vol. 151, No. 2, pp. 621-627 (Jul. 15, 1993).
Mizushima et al, Nucleic Acids Research, vol. 18, No. 17, pp. 5322 (1990).
Loetscher et al, The Journal of Biological Chemistry, vol. 266, No. 27, pp. 18324-18329 (Sep. 25, 1991).
Shaw et al, Nucleic Acids Research, vol. 11, No. 3 (1983).
Morishita et al, Thrombosis Research, vol. 73, Nos. 3/4, pp. 193-204 (1994).
Suda et al, Cell, vol. 75, pp. 1169-1178 (Dec. 17, 1993).
Suda et al, J. Exp. Med., vol. 179, pp. 873-879 (Mar. 1994).
Takahashi et al, Cell, vol. 76, pp. 969-976 (Mar. 25, 1994).
Cory, Nature, vol. 367, pp. 317-318 (Jan. 27, 1994).
Takahashi et al, International Immunology, vol. 6, No. 10, pp. 1567-1574 (1994).

Affiliated with

Also associated with

Rating

Antibodies and fragments thereof to Fas ligand and Fas... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies and fragments thereof to Fas ligand and Fas..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies and fragments thereof to Fas ligand and Fas... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3436083